115 related articles for article (PubMed ID: 1785290)
1. Specific antibodies to poliovirus type I in breastmilk of unvaccinated mothers before and seven years after start of community-wide vaccination of their infants with live, oral poliovirus vaccine.
Zaman S; Carlsson B; Jalil F; Jeansson S; Mellander L; Hanson LA
Acta Paediatr Scand; 1991 Dec; 80(12):1174-82. PubMed ID: 1785290
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus antibody titres, relative affinity, and neutralising capacity in maternal milk.
Zaman S; Carlsson B; Morikawa A; Jeansson S; Narayanan I; Thiringer K; Jalil F; Hanson LA
Arch Dis Child; 1993 Feb; 68(2):198-201. PubMed ID: 8386918
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing activity and secretory IgA antibodies reactive with rotavirus SA-11 (serotype G3) in colostrum and milk from Brazilian women.
Tino De Franco M; Vieira PD; Santos SM; Ferreira TL; Araújo ED; Quintal VS; Carbonare SB
Paediatr Int Child Health; 2013 May; 33(2):102-7. PubMed ID: 23925284
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum and salivary antibodies in children vaccinated with oral live or parenteral inactivated poliovirus vaccines of different antigen concentrations.
Zaman S; Carlsson B; Jalil F; Mellander L; Van Wezel AL; Böttiger M; Hanson LA
Acta Paediatr Scand; 1991 Dec; 80(12):1166-73. PubMed ID: 1785289
[TBL] [Abstract][Full Text] [Related]
5. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines.
Hanson LA; Carlsson B; Jalil F; Lindblad BS; Khan SR; van Wezel AL
Rev Infect Dis; 1984; 6 Suppl 2():S356-60. PubMed ID: 6740073
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
[TBL] [Abstract][Full Text] [Related]
7. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.
Sanz-Ramos M; Manno D; Kapambwe M; Ndumba I; Musonda KG; Bates M; Chibumbya J; Siame J; Monze M; Filteau S; Gompels UA;
Vaccine; 2013 Apr; 31(16):2042-9. PubMed ID: 23474309
[TBL] [Abstract][Full Text] [Related]
8. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
10. Studies on human milk III. Secretory IgA quantity and antibody levels against Escherichia coli in colostrum and milk from underprivileged and privileged mothers.
Cruz JR; Carlsson B; García B; Gebre-Medhin M; Hofvander Y; Urrutia JJ; Hanson LA
Pediatr Res; 1982 Apr; 16(4 Pt 1):272-6. PubMed ID: 7043383
[TBL] [Abstract][Full Text] [Related]
11. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
12. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
14. Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.
Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
Trans R Soc Trop Med Hyg; 2019 Mar; 113(3):110-115. PubMed ID: 30576507
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.
Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
Hum Vaccin Immunother; 2017 Nov; 13(11):2543-2547. PubMed ID: 28857649
[TBL] [Abstract][Full Text] [Related]
16. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
[TBL] [Abstract][Full Text] [Related]
17. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
19. Determination of poliovirus-specific IgA in saliva by ELISA tests.
Ivanov A; Dragunsky E; Ivanova O; Rezapkin G; Potapova S; Chumakov K
J Virol Methods; 2005 Jun; 126(1-2):45-52. PubMed ID: 15847918
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]